Board Meetings for ALIVUS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ALIVUS | Alivus Life Sciences Limited | 25 Apr 2024 | Financial Results | To consider and approve the financial results for the period ended March 31, 2024 | |
| ALIVUS | Alivus Life Sciences Limited | 23 Jan 2024 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 23-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 23 Jan 2024 | Financial Results | To consider and approve the financial results for the period ended December 31, 2023 | |
| ALIVUS | Alivus Life Sciences Limited | 20 Oct 2023 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 20-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 20 Oct 2023 | Financial Results | To consider and approve the financial results for the period ended September 30, 2023 | |
| ALIVUS | Alivus Life Sciences Limited | 09 Oct 2023 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 09-Oct-2023 to consider Dividend. | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 09 Oct 2023 | Dividend | To consider dividend | |
| ALIVUS | Alivus Life Sciences Limited | 21 Jul 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| ALIVUS | Alivus Life Sciences Limited | 21 Jul 2023 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 21-Jul-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 27 Apr 2023 | GLENMARK LIFE SCIENCES LIMITEDhas informed the Exchange about Board Meeting to be held on 27-Apr-2023to inter-alia consider and approve the Audited financial results of the Company for the Yearly ended March 2023 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 27 Apr 2023 | Financial Results | To consider and approve the financial results for the period ended March 31, 2023 | |
| ALIVUS | Alivus Life Sciences Limited | 16 Mar 2023 | Dividend | We have to inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Thursday, March 16, 2023, inter alia, to consider and declare payment of interim dividend, if any, on Equity Shares for the financial year 2022-23. | |
| ALIVUS | Alivus Life Sciences Limited | 27 Jan 2023 | Financial Results | We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, January 27, 2023, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third quarter and Nine months ended December 31, 2022.Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from December 31, 2022 to January 29, 2023 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Third quarter and Nine months ended December 31, 2022. | |
| ALIVUS | Alivus Life Sciences Limited | 21 Oct 2022 | Financial results | Glenmark Life Sciences Limited has informed the Exchange about Board Meeting to be held on 21-Oct-2022 to consider financial statements for the period ended September 2022 | |
| ALIVUS | Alivus Life Sciences Limited | 04 Aug 2022 | Financial results | Glenmark Life Sciences Limited has informed the Exchange about Board Meeting to be held on 04-Aug-2022 to consider financial statements for the period ended June 2022 |